These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34704193)
1. Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia. Viana R; D'Alessio D; Grant L; Cooper N; Arnold D; Morgan M; Provan D; Cuker A; Hill QA; Tomiyama Y; Ghanima W Adv Ther; 2021 Dec; 38(12):5791-5808. PubMed ID: 34704193 [TBL] [Abstract][Full Text] [Related]
2. Japanese and French translation and linguistic validation of a patient-reported outcome tool to assess quality of life in patients with Immune Thrombocytopenia (ITP): the ITP Life Quality Index (ILQI). Tomiyama Y; Cheze S; Grant L; Bonner N; Affinito S; Nagano M; Rajput T; Viana R Int J Hematol; 2022 Oct; 116(4):500-527. PubMed ID: 35675024 [TBL] [Abstract][Full Text] [Related]
3. Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI). Cooper N; Cuker A; Bonner N; Ghanima W; Provan D; Morgan M; Taylor B; D'Alessio D; Arnold D; Viana R Br J Haematol; 2021 Aug; 194(4):759-766. PubMed ID: 34263940 [TBL] [Abstract][Full Text] [Related]
4. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914 [TBL] [Abstract][Full Text] [Related]
5. How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh). Chakrabarti P; George B; Shanmukhaiah C; Sharma LM; Udupi S; Ghanima W J Patient Rep Outcomes; 2022 Mar; 6(1):24. PubMed ID: 35303181 [TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in children with chronic immune thrombocytopenia in China. Zhang H; Wang L; Quan M; Huang J; Wu P; Lu Q; Fang Y Health Qual Life Outcomes; 2016 Mar; 14():45. PubMed ID: 26979950 [TBL] [Abstract][Full Text] [Related]
7. Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life. Cooper N; Kruse A; Kruse C; Watson S; Morgan M; Provan D; Ghanima W; Arnold DM; Tomiyama Y; Santoro C; Michel M; Laborde S; Lovrencic B; Hou M; Bailey T; Taylor-Stokes G; Haenig J; Bussel JB Am J Hematol; 2021 Feb; 96(2):199-207. PubMed ID: 33107998 [TBL] [Abstract][Full Text] [Related]
8. Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment. Cooper N; Kruse A; Kruse C; Watson S; Morgan M; Provan D; Ghanima W; Arnold DM; Tomiyama Y; Santoro C; Michel M; Laborde S; Lovrencic B; Hou M; Bailey T; Taylor-Stokes G; Haenig J; Bussel JB Am J Hematol; 2021 Feb; 96(2):188-198. PubMed ID: 33170956 [TBL] [Abstract][Full Text] [Related]
9. ITP-QoL questionnaire for children with immune thrombocytopenia: Italian version validation's. Giordano P; Lassandro G; Giona F; Jankovic M; Nardi M; Nobili B; Notarangelo LD; Russo G; Mackensen Sv Pediatr Hematol Oncol; 2014 Sep; 31(6):534-47. PubMed ID: 24852656 [TBL] [Abstract][Full Text] [Related]
10. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL Health Qual Life Outcomes; 2007 Feb; 5():11. PubMed ID: 17316442 [TBL] [Abstract][Full Text] [Related]
11. Fatigue and health-related quality of life in patients with immune thrombocytopenia: a longitudinal assessment in China. Zhang W; Xie S; Fu R; Chen Y; Liu W; Sun T; Ju M; Li H; Xue F; Zhang L; Liu X; Yang R Expert Rev Hematol; 2023; 16(12):1125-1133. PubMed ID: 38009277 [TBL] [Abstract][Full Text] [Related]
12. Psychometric evaluation of a patient-reported outcomes instrument for congenital thrombotic thrombocytopenic purpura. Oladapo A; Ito D; Rodriguez AM; Philpott S; Krupnick R; Allen V; Hibbard C; Scully M; Ewenstein B J Patient Rep Outcomes; 2023 Jul; 7(1):68. PubMed ID: 37450201 [TBL] [Abstract][Full Text] [Related]
13. Patient-centric care in primary immune thrombocytopenia (ITP): shared decision-making and assessment of health-related quality of life. Maitland H; Lambert C; Ghanima W Hematology; 2024 Dec; 29(1):2375177. PubMed ID: 38975804 [No Abstract] [Full Text] [Related]
14. Immune thrombocytopenic purpura: epidemiology and implications for patients. Michel M Eur J Haematol Suppl; 2009 Mar; (71):3-7. PubMed ID: 19200301 [TBL] [Abstract][Full Text] [Related]
15. [A physician-patient survey for primary immune thrombocytopenia: Chinese subgroup analysis of I-WISh International Survey]. Wang RT; Liu XG; Hou Y; Hou M Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):369-375. PubMed ID: 34218578 [No Abstract] [Full Text] [Related]
16. Health-related quality of life in adult primary immune thrombocytopenia. Sestøl HG; Trangbæk SM; Bussel JB; Frederiksen H Expert Rev Hematol; 2018 Dec; 11(12):975-985. PubMed ID: 30444433 [No Abstract] [Full Text] [Related]
17. Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Mathias SD; Gao SK; Miller KL; Cella D; Snyder C; Turner R; Wu A; Bussel JB; George JN; McMillan R; Wysocki DK; Nichol JL Health Qual Life Outcomes; 2008 Feb; 6():13. PubMed ID: 18261217 [TBL] [Abstract][Full Text] [Related]
18. Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP. Rüfer A; Terrell DR Br J Haematol; 2023 Oct; 203(1):79-85. PubMed ID: 37735553 [TBL] [Abstract][Full Text] [Related]
19. Quality of life in childhood immune thrombocytopenia: Revision of the Kids' ITP Tools (KIT). Dhir V; Zhang C; Sucha E; Barrowman N; Grace RF; Grainger JD; Young NL; Klaassen RJ Br J Haematol; 2024 Oct; 205(4):1489-1496. PubMed ID: 39072718 [TBL] [Abstract][Full Text] [Related]
20. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents. Barnard D; Woloski M; Feeny D; McCusker P; Wu J; David M; Bussel J; Lusher J; Wakefield C; Henriques S; Blanchette V; J Pediatr Hematol Oncol; 2003 Jan; 25(1):56-62. PubMed ID: 12544774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]